Cytotoxic action of methylquercetins in human lung adenocarcinoma cells

Oncology Letters

Volumn 15, Issue 2, 2018, Pages 1973-1978

  Sak, Katrin ^a   Lust, Helen ^a   Kase, Marju ^b   Jaal, Jana ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Adenocarcinoma; Flavonoids; Isorhamnetin; Methylated metabolites of flavonoids; Non small cell lung cancer; Quercetin; Tamarixetin

Indexed keywords

CASPASE; CASPASE 3; ISORHAMNETIN; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCETIN 3 METHYL ETHER; TAMARIXETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC50; LUNG ADENOCARCINOMA; MTT ASSAY; NON SMALL CELL LUNG CANCER;

EID: 85038411954     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.7466     Document Type: Article

References (45)

1. Lemjabbar-Alaoui H, Hassan OU, Yang YW and Buchanan P: Lung cancer: Biology and treatment options. Biochim Biophyc Acta 1856: 189-210, 2015.
2. Aggarwal A, Lewison G, Idir S, Peters M, Aldige C, Boerckel W, Boyle P, Trimble EL, Roe P, Sethi T, et al: The state of lung cancer research: A global analysis. J Thorac Oncol 11: 1040-1050, 2016.
3. McIntyre A and Ganti AK: Lung cancer-A global perspective. J Surg Oncol 115: 550-554, 2017.
4. Zappa C and Mousa SA: Non-small cell lung cancer: Current treatment and future advances. Transl Lung Cancer Res 5: 288-300, 2016.
5. Alberg AJ, Wallace K, Silvestri GA and Brock MV: Invited commentary: The etiology of lung cancer in men compared with women. Am J Epidemiol 177: 613-616, 2013.
6. Fu JB, Kau TY, Severson RK and Kalemkerian GP: Lung cancer in women: Analysis of the national surveillance, epidemiology and end results database. Chest 127: 768-777, 2005.
7. Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA and Garver RI: Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest 130: 1796-1802, 2006.
8. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern Cooperative Oncology Group: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98, 2002.
9. Boffetta P, Couto E, Wichmann J, Ferrari P, Trichopoulos D, Bueno-de-Mesquita HB, van Duijnhoven FJ, Büchner FL, Key T, Boeing H, et al: Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 102: 529-537, 2010.
10. Miller AB, Altenhurg HP, Bueno-de-Mesquita B, Boshuizen HC, Agudo A, Berrino F, Gram IT, Janson L, Linseisen J, Overvad K, et al: Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 108: 269-276, 2004.
11. Linseisen J, Rohrmann S, Miller AB, Bueno-de-Mesquita HB, Büchner FL, Vineis P, Agudo A, Gram IT, Janson L, Krogh V, et al: Fruit and vegetable consumption and lung cancer risk: Updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 121: 1103-1114, 2007.
12. Büchner FL, Bueno-de-Mesquita HB, Ros MM, Overvad K, Dahm CC, Hansen L, Tjønneland A, Clavel-Chapelon F, BoutronRuault MC, Touillaud M, et al: Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 19: 2278-2286, 2010.
13. Wang M, Qin S, Zhang T, Song X and Zhang S: The effect of fruit and vegetable intake on the development of lung cancer: A meta-analysis of 32 publications and 20,414 cases. Eur J Clin Nutr 69: 1184-1192, 2015.
14. Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen YM and Li HB: Natural polyphenols for prevention and treatment of cancer. Nutrients 8: pii: E515, 2016.
15. Amararathna M, Johnston MR and Rupasinghe HP: Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci 17: pii: E1352, 2016.
16. Patil BS, Jayaprakasha GK, Chidambara Murthy KN and Vikram A: Bioactive compounds: Historical perspectives, opportunities, and challenges. J Agric Food Chem 57: 8142-8160, 2009.
17. Sak K: Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 8: 122-146, 2014.
18. Cassidy A and Minihane AM: The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr 105: 10-22, 2017.
19. Chen Z, Zheng S, Li L and Jiang H: Metabolism of flavonoids in human: A comprehensive review. Curr Drug Metab 15: 48-61, 2014.
20. Sak K: The Val158Met polymorphism in COMT gene and cancer risk: Role of endogenous and exogenous catechols. Drug Metab Rev 49: 56-83, 2017.
21. Cao Y, Chen ZJ, Jiang HD and Chen JZ: Computational studies of the regioselectivities of COMT-catalyzed meta-/para-O methylations of luteolin and quercetin. J Phys Chem B 118: 470-481, 2014.
22. Lieber M, Smith B, Szakal A, Nelson-Rees W and Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62-70, 1976.
23. Gazdar AF, Girard L, Lockwood WW, Lam WL and Minna JD: Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 102: 1310-1321, 2010.
24. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
25. Kupcsik L: Estimation of cell number based on metabolic activity: The MTT reduction assay. Methods Mol Biol 740: 13-19, 2011.
26. Loizzo MR, Said A, Tundis R, Hawas UW, Rashed K, Menichini F, Frega NG and Menichini F: Antioxidant and anti-proliferative activity of Diospyros lotus L. extract and isolated compounds. Plant Foods Hum Nutr 64: 264-270, 2009.
27. Tan J, Wang B and Zhu L: DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex. Bioorg Med Chem 17: 614-620, 2009.
28. Tan J, Wang B and Zhu L: DNA binding and oxidative DNA damage induced by a quercetin copper(II) complex: Potential mechanism of its antitumor properties. J Biol Inorg Chem 14: 727-739, 2009.
29. Tan J, Zhu L and Wang B: From GC-rich DNA binding to the repression of survivin gene for quercetin nickel(II) complex: Implications for cancer therapy. Biometals 23: 1075-1084, 2010.
30. Robaszkiewicz A, Balcerczyk A and Bartosz G: Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 31: 1245-1250, 2007.
31. Chan ST, Yang NC, Huang CS, Liao JW and Yeh SL: Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS One 8: e54255, 2013.
32. Katalinic M, Rusak G, Domaćinović Barović J, Sinko G, Jelić D, Antolović R and Kovarik Z: Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur J Med Chem 45: 186-192, 2010.
33. Kawaii S, Tomono Y, Katase E, Ogawa K and Yano M: Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 63: 896-899, 1999.
34. Kim DH, Jung EA, Sohng IS, Han JA, Kim TH and Han MJ: Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 21: 17-23, 1998.
35. Hernandez J, Goycoolea FM, Quintero J, Acosta A, Castañeda M, Dominguez Z, Robles R, Vazquez-Moreno L, Velazquez EF, Astiazaran H, et al: Sonoran propolis: Chemical composition and antiproliferative activity on cancer cell lines. Planta Med 73: 1469-1474, 2007.
36. Said A, Tundis R, Hawas UW, El-Kousy SM, Rashed K, Menichini F, Bonesi M, Huefner A, Loizzo MR and Menichinib F: In vitro antioxidant and antiproliferative activities of flavonoids from Ailanthus excelsa (Roxb.) (Simaroubaceae) leaves. Z Naturforsch C 65: 180-186, 2010.
37. Han BJ, Li W, Jiang GB, Lai SH, Zhang C, Zeng CC and Liu YJ: Effects of daidzein in regards to cytotoxicity in vitro, apoptosis, reactive oxygen species level, cell cycle arrest and the expression of caspase and Bcl-2 family proteins. Oncol Rep 34: 1115-1120, 2015.
38. Yang Y, Zang A, Jia Y, Shang Y, Zhang Z, Ge K, Zhang J, Fan W and Wang B: Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling. Oncol Lett 12: 2189-2193, 2016.
39. Kano M, Takayanagi T, Harada K, Sawada S and Ishikawa F: Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 136: 2291-2296, 2006.
40. Manach C, Williamson G, Morand C, Scalbert A and Rémésy C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (1 Suppl): 230S-242S, 2005.
41. Lee J and Mitchell AE: Pharmacokinetics of quercetin absorption from apples and onions in healthy humans. J Agric Food Chem 60: 3874-3881, 2012.
42. Sak K and Everaus H: Sulfotransferase 1A1 as a biomarker for susceptibility to carcinogenesis: From molecular genetics to the role of dietary flavonoids. Curr Drug Metab 17: 528-541, 2016.
43. Ruan Y, Hu K and Chen H: Autophagy inhibition enhances isorhamnetin-induced mitochondria-dependent apoptosis in non-small cell lung cancer cells. Mol Med Rep 12: 5796-5806, 2015.
44. Zhang BY, Wang YM, Gong G, Zhao H, Lv XY, Yuan GH and Han SR: Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cisplatin and carboplatin in non-small cell lung carcinoma (NSCLC). Int J Clin Exp Pathol 8: 25-37, 2015.
45. Li Q, Ren FQ, Yang CL, Zhou LM, Liu YY, Xiao J, Zhu L and Wang ZG: Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo. Asian Pac J Cancer Prev 16: 3035-3042, 2015.